Launched in early 2022, CoVICIS represents a global approach to combatting the SARS-CoV-2 pandemic, coupling powerful state-of-the-art virologic and immunologic platforms with large genomic surveillance studies and diverse cohorts in Europe and sub-Saharan Africa (SSA).

Professor Puhan joins us to discuss the three prospective cohort studies, including children, adolescents, and adults, based at EBPI that are contributing to the CoVICIS project.

Professor Puhan joins us to discuss the three prospective cohort studies, including children, adolescents, and adults, based at EBPI that are contributing to the CoVICIS project.